Literature DB >> 6250762

Poisoning with 4-aminopyridine: report of three cases.

D A Spyker, C Lynch, J Shabanowitz, J A Sinn.   

Abstract

Four-aminopyridine is an acutely toxic avicide considered by the manufacturer to be a bird "repellant" because only a small number of birds are acutely poisoned, become disoriented, and emit a distress cry frightening other members of the flock. Four-aminopyridine dramatically enhances transmission at the neuromuscular junction and other synapses, and has been employed clinically in the treatment of prolonged paralysis caused by antibiotics and muscle relaxants, and in the Eaton-Lambert syndrome. In this paper we report the results of an acute poisoning misadventure in three adult males. We review the animal toxicology, summarize the neurophysiological research using 4-AP as a potassium channel blocker, comment on clinical applications, and outline the management of overdose with this agent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250762     DOI: 10.3109/15563658008989978

Source DB:  PubMed          Journal:  Clin Toxicol        ISSN: 0009-9309            Impact factor:   4.467


  12 in total

1.  Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.

Authors:  Gabriela Mora; Ricardo Tapia
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  A review of 29 incidents involving 4-aminopyridine in non-target species reported to the ASPCA Animal Poison Control Center.

Authors:  Mary Kay McLean; Safdar Khan
Journal:  J Med Toxicol       Date:  2013-12

Review 3.  [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].

Authors:  L Husseini; V I Leussink; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 4.  4-aminopyridine toxicity: a case report and review of the literature.

Authors:  Andrew M King; Nathan B Menke; Kenneth D Katz; Anthony F Pizon
Journal:  J Med Toxicol       Date:  2012-09

5.  Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices.

Authors:  A E Watts; J G Jefferys
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Phencyclidine in low doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain.

Authors:  D K Bartschat; M P Blaustein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

7.  The behavioral effects of phencyclidines may be due to their blockade of potassium channels.

Authors:  E X Albuquerque; L G Aguayo; J E Warnick; H Weinstein; S D Glick; S Maayani; R K Ickowicz; M P Blaustein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo.

Authors:  Luis E Gonzalez-Reyes; Thomas P Ladas; Chia-Chu Chiang; Dominique M Durand
Journal:  Exp Neurol       Date:  2013-10-18       Impact factor: 5.330

Review 9.  Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions.

Authors:  Doodipala Samba Reddy; Ramkumar Kuruba
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

10.  Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function.

Authors:  Meheroz H Rabadi; Kimberly Kreymborg; Andrea S Vincent
Journal:  Drugs R D       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.